Mars Petcare And Diversigen Collaborate In One Of The Largest Ever Microbiome Studies To Evaluate Pet Health
OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health BETHLEHEM, Pa., September 14, 2022 (Globe Newswire) – OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today a new collaboration between Diversigen, Inc., a subsidiary of OraSure […]
Highlighting our presentations at the Precision Medicine World Conference 2022
Defining precision medicine and its aim Precision medicine—occasionally referred to as “personalized medicine”—is an approach or medical model that promotes customizing and tailoring healthcare based on an individual’s underlying biological traits. The driving force behind precision medicine is the progress being made in the “big data” movement including genomics, transcriptomics, metabolomics, microbiomics, and the accompanying […]
Prolacta Bioscience publishes new research showing reversible engraftment using a synbiotic of B. infantis and HMO in healthy adult microbiomes without antibiotics
Prolacta Bioscience has published new research successfully using a synbiotic of human milk oligosaccharides (HMOs) with Bifidobacterium longum subsp. infantis (B. infantis) to reversibly engraft the microbe within healthy human adult microbiomes without the use of antibiotics. Within the infant microbiome, HMOs are uniquely metabolized by B. infantis to produce short-chain fatty acids such as […]
Current progress in microbiome biomarker discovery
The human microbiome: defining microbiome biomarkers The microbiome, home to trillions of bacteria, fungi, and viruses, is comprised of 10-fold more cells than the human body.1 Potentially impacting the health and wellbeing of the host, these microbes directly interact with host cells and metabolic pathways. Researchers profiling the microbiome have begun identifying microbial signatures within […]
Mouse microbiome platform for translational mouse model research: MetaGene Mouse
With over 99% mouse gene homologs in humans, mouse models provide valuable insights into the pathogenesis and treatment of human diseases like cancer, diabetes and obesity.
Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board
Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board Joins Diversigen’s Scientific Advisory Board Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board PAUL, MN, January 25, 2021 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ: OSUR), today announced that Eric Pamer, M.D., Professor of Medicine, Section of Infectious […]
Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study
ST. PAUL, MN, June 25, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced they have signed a collaboration agreement for a research study on patients with Acute Severe Ulcerative Colitis (ASUC). The study, titled: “Pharmacokinetics of Infliximab and Tumor Necrosis Factor Concentrations in […]
Diversigen Inc. Selected by Nom NomTM as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Services
PAUL, MN and OAKLAND, CA, May 22, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Nom NomTM, a direct-to-consumer pet health brand, today announced that Nom Nom has selected Diversigen as their preferred provider for metagenomics and microbiome sequencing and analysis services. Diversigen will also serve as Nom Nom’s central lab […]
OraSure Technologies, Inc. Consolidates Microbiome Services Subsidiaries
OraSure Technologies, Inc. announces that its Diversigen and CoreBiome subsidiaries have combined their microbiome service offerings under the Diversigen name. The rebrand highlights the combined companies’ unparalleled scientific bench strength, state-of-the-art laboratory, ability to translate data to insights and collective focus on quality and service. Investor Contact: Roberto Cuca Chief Financial Officer 610-882-1820 investorinfo@orasure.com Media Contact: […]
Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test
CARLSBAD, Calif., Dec. 17, 2019 — Prescient Metabiomics, a subsidiary of Prescient Medicine Holdings, Inc., and CoreBiome, a wholly owned subsidiary of OraSure Technologies, Inc., announced today a collaboration to develop a new test called LifeKit® Prevent, which may represent a microbiome-driven paradigm shift in colon cancer screening. According to the American Cancer Society, colorectal cancer is the third […]
